Sundrug Co.,Ltd. (TYO:9989)
Japan flag Japan · Delayed Price · Currency is JPY
3,656.00
+44.00 (1.22%)
Oct 23, 2026, 3:30 PM JST

Sundrug Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Sundrug stock has a consensus rating of "Buy" and an average price target of ¥4,674. The average 1-year stock price forecast is 27.85% higher than the current stock price, while the lowest is ¥3,820 (+4.49%) and the highest is ¥5,600 (+53.17%).

Price Target: ¥4,674 (+27.85%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥3,820¥4,674¥4,600¥5,600
Change+4.49%+27.85%+25.82%+53.17%

Analyst Ratings

The average analyst rating for Sundrug stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Oct '26
Strong Buy222222
Buy222222
Hold333333
Sell000000
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
UBS
No rating
UBS
Hold
Maintains
¥4,030 → ¥3,820
HoldMaintains¥4,030 → ¥3,820+4.49%Oct 6, 2026
Unknown Analyst
Bank of America Securities
No rating
Bank of America Securities
Buy
Maintains
¥4,600
BuyMaintains¥4,600+25.82%Aug 17, 2026
Unknown Analyst
SMBC Nikko
No rating
SMBC Nikko
Hold
Maintains
¥4,200
HoldMaintains¥4,200+14.88%Jun 3, 2026
Unknown Analyst
Mizuho Securities
No rating
Mizuho Securities
Buy
Maintains
¥5,100
BuyMaintains¥5,100+39.50%May 22, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
893.64B
from 842.51B
Increased by 6.07%
Revenue Next Year
949.19B
from 893.64B
Increased by 6.22%
EPS This Year
283.59
from 268.36
Increased by 5.68%
EPS Next Year
303.48
from 283.59
Increased by 7.01%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
648.73B690.46B751.78B801.81B842.51B893.64B
Revenue Growth
2.27%6.43%8.88%6.65%5.08%6.07%
Gross Profit
156.51B171.95B189.32B204.09B216.17B229.16B
Gross Margin
24.12%24.90%25.18%25.45%25.66%25.64%
Operating Income
34.05B37.45B41.00B44.50B46.83B50.04B
Net Income
23.85B25.70B29.13B30.75B31.39B33.14B
EPS
204.01219.82249.06262.90268.36283.59
EPS Growth
-5.83%7.75%13.30%5.56%2.07%5.68%
Forward PE
13.1616.0118.0615.3913.4412.89
Dividend / Share
71.00100.00114.00130.00131.00138.00
Dividend Growth
1.43%40.85%14.00%14.04%0.77%5.34%
Free Cash Flow
----12.96B14.99B
No. Analysts
-----7
Financial currency is JPY.

Revenue Forecast

Revenue202720282029
High905.0B
Avg893.6B
Low876.0B

Revenue Growth

Revenue Growth202720282029
High
7.4%
Avg
6.1%
Low
4.0%

EPS Forecast

EPS202720282029
High294.90
Avg283.59
Low272.69

EPS Growth

EPS Growth202720282029
High
9.9%
Avg
5.7%
Low
1.6%